“ADVERSE FETOMATERNAL OUTCOMES IN WOMEN WITH HELLP SYNDROME” (2024) Journal of Population Therapeutics and Clinical Pharmacology, 31(4), pp. 2274–2281. doi:10.53555/mfrm8v65.